Since its founding in 1954, IMS has served the pharmaceutical and healthcare industries with expertise and insights for advancing world health.
IMS's Consulting and Services teams in the Asia-Pacific offer the strategic planning and decision-making support clients need to meet critical market challenges, both locally and regionally.
Its industry experience and expertise, in combination with its data, applications and offerings, help simplify market complexities and develop strategies that lead to successful sales, marketing and promotional programs
IMS is the leading provider of business intelligence and strategic consulting services for the pharmaceutical and healthcare industries. It is a global company, with 7,600+ employees and a presence in 100+ countries worldwide.
Its business begins with the data it gathers on an unmatched scale. It's the raw material it collects from 29,000 data suppliers at 225,000 supplier sites worldwide. IMS monitors 75 percent of prescription drug sales in over 100 countries, and 90 percent of U.S. sales. IMS tracks 1 million+ products from more than 3,000 active drug manufacturers. IMS conducts medical audits in over 45 countries. IMS processes 1 billion transactions a month. And the 60+ terabytes of information in its databases are accessible to customers around the clock.
IMS Health acquired United Research China (URC) Shanghai in 2004, a company that offers comprehensive coverage of China's over-the-counter (OTC) market, as well as Consumer Health consulting services.